{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13216",
      "entity_text" : "CsA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "A second difference to the most widespread immunosuppressive regimens are the CsA target levels of 150-300 ng/mL in the first month and 100-250 ng/mL from month 2-12 in the core study.",
  "reading_complete" : "2020-08-04T13:04:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:04:27Z",
  "trigger" : "levels",
  "evidence" : [ "CsA target levels" ],
  "pmc_id" : "5182231",
  "score" : 0
}